研究業績：英文
教室研究業績: 英文（2024年〜）
◎2025
- Muchtar A#, Onomura D#, Ding D, Nishitsuji H, Shimotono K, Okada S, Ueda K, Watashi K, Wakita T, Iida K, Yoshiyama H*, Iizasa H*. MicroRNA-3145 as a potential therapeutic target for hepatitis B virus: inhibition of viral replication via downregulation of HBS and HBX. Front Microbiol 15:1499216 (2025) https://doi.org/10.3389/fmicb.2024.1499216 (IF: 4) (#Equal contribution, *Corresponding author)
- Wai AP, Richardo T, Wakae K, Okada S, Muramatsu M, Yoshiyama H*, Iizasa H*. Epstein-Barr virus infection induces mitochondrial DNA mutations via APOBEC3C expression in gastric epithelial cells. Microbiol Immunol 69:157-167 (2025) https://doi.org/10.1111/1348-0421.13196 (IF: 1.9) (*Corresponding author)
◎2024
- Kimura T, Sakata KI, Ohga N, Sato J, Itagaki T, Munekata T, Yanagawa-Matsuda A, Maeda T, Hojo M, Hatanaka KC, Hatanaka Y, Iizasa H. Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case report. Oncol Lett 29(1):52 (2024) https://doi.org/10.3892/ol.2024.14798 (IF: 2.5)
- Liu Y, Wai AP, Iida Y, Tumurgan Z, Okada S, Iizasa H*, Yoshiyama H*. Exploring the anti-EBV potential of suberoylanilide hydroxamic acid: leading apoptosis in infected cells by suppressing BART gene expression and inducing lytic infection. Virology 597:110161 (2024) https://doi.org/10.1016/j.virol.2024.110161 (IF: 2.8) (*Corresponding author)
- Wadi AFAA, Onomura D, Funamori H, Khatun MM, Okada S, Iizasa H, Yoshiyama H*. Effect of strain differences, humidity changes, and saliva contamination on inactivation of SARS-CoV-2 by ions. Viruses 16(4):520 (2024) https://doi.org/10.3390/v16040520 (IF: 3.8) (*Corresponding author)